Abstract
Patients with head and neck squamous cell carcinoma (HNSCC) and a low level of hemoglobin often have a poor response to radiation that may be related to hypoxia-induced radioresistance. We have previously published the importance of hemoglobin level and the effect of transfusion by the results from the randomized DAHANCA 5 trial, including 414 patients in the analysis. Aim of the current analysis was to gain additional power by adding patients from the continued subrandomization in the DAHANCA 7 trial, now including a total of almost 1200 patients.
Original language | English |
---|---|
Journal | Acta Oncologica |
Volume | 50 |
Pages (from-to) | 1006-14 |
Number of pages | 9 |
ISSN | 0284-186X |
DOIs | |
Publication status | Published - 2011 |
Externally published | Yes |
Keywords
- Adult
- Aged
- Carcinoma, Squamous Cell
- Combined Modality Therapy
- Erythrocyte Transfusion
- Female
- Head and Neck Neoplasms
- Hemoglobins
- Humans
- Male
- Middle Aged
- Nimorazole
- Radiotherapy
- Survival Analysis